Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New motorized device aims to improve hernia surgery outcomes

NCT ID NCT06710795

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times

Summary

This study is testing the MaxTack motorized fixation device, which helps surgeons attach mesh during minimally invasive ventral hernia repair. Researchers are tracking how often complications like infection or hernia recurrence happen within 3 months after surgery. The study involves 35 adults undergoing elective hernia repair.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MaxTack™ Motorized Fixation Device
What this could lead to
If successful, this device could offer a safer, more reliable way to fix mesh during hernia surgery, reducing complications like infections or hernia return.
What could go wrong
This is a small, single-arm study with only 35 participants, so results may not apply to everyone. The device could still cause side effects like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Jun 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Preoperative Inclusion Criteria: 1. Subject has provided informed consent (IC) 2. Subject is 18 years of age or older at the time of consent 3. Subject is able and willing to comply with the study requirements and follow-up schedule 4. Subject is undergoing an elective, single-stage, primary or incisional ventral hernia repair 5. Subject is undergoing minimally invasive ventral hernia repair procedure using the MaxTack™ Motorized Fixation Device 6. Subject is undergoing minimally invasive ventral hernia repair procedure using a Medtronic (including Covidien) mesh that is intended to be used in compliance with the mesh Instructions for Use (IFU) 7. Subject is expected to meet the criteria for a class I wound (clean) as defined by Centers for Disease Control and Prevention (CDC) classification Preoperative Exclusion Criteria: 1. Subject is undergoing an emergency surgery (e.g., lifesaving procedures performed where subject is in imminent danger of death, strangulated hernia, etc.) 2. Subject has history of 3 or more hernia repair procedures 3. Subject has existing mesh in the space where the physician needs to apply the new mesh to be fixated with the MaxTack™ Motorized Fixation Device 4. Subject is scheduled (or anticipated to be scheduled) for additional surgery, and subsequent surgery would jeopardize previous application of study treatment 5. Subject has history of allergic reactions to Poly (Glycolide-co-L-lActide) (PGLA) 6. Subject has history of allergic reactions to the components of the intended mesh 7. Subject has any systemic or local ongoing infection at the time of the surgery 8. Subject has a Body Mass Index (BMI) greater than 45 kg/m2 9. Subject has life expectancy in the opinion of the investigator, of less than 3 years at the time of enrollment 10. Subject is pregnant (as determined by standard site practices) or is planning to become pregnant during study duration period. 11. Subject has participated or will participate in an investigational drug or device research study that would interfere with the results of this study 12. Subject's participation in the study may jeopardize the safety or welfare of the subject, as determined by the investigator 13. Subject is already enrolled or was previously enrolled in this study Intraoperative Exclusion Criteria: 1. Subject did not receive the MaxTack™ Motorized Fixation Device tacks to fixate the mesh 2. Subject did not receive a Medtronic (including Covidien) mesh 3. Inability to comply with the mesh IFU 4. Subject required more than a single piece of mesh 5. Subject has a surgical wound classified as Class II (clean-contaminated), Class III (contaminated) or Class IV (dirty/infected) as defined by the CDC classification 6. Subject with an American Society of Anesthesiologists (ASA) score of Class 4, 5, or 6 7. Inability to close the hernia defect 8. Subject's procedure required a multi-stage repair 9. Subject's minimally invasive procedure required to convert to open

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ventral hernia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hernia, Ventral

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic - Ohio

    Cleveland, Ohio, 44195, United States

  • Cleveland Clinic - Weston Hospital

    Weston, Florida, 33331, United States

  • The Ohio State University

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.